Wells Fargo’s ProShares Ultra Health Care RXL Stock Holding History

Wells Fargo’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75	Hold	1	–	–	﹤0.01%	6676
2026 Q1	$61	Buy	+1	New	+$51	﹤0.01%	6564
2025 Q4	–	Sell	-1	Closed	-$49	–	6693
2025 Q3	$33	Hold	1	–	–	﹤0.01%	6583
2025 Q2	$23	Hold	1	–	–	﹤0.01%	6754
2025 Q1	$41	Hold	1	–	–	﹤0.01%	6497
2024 Q4	$37	Sell	1 -1	-50%	-$50	﹤0.01%	6561
2024 Q3	$72	Hold	2	–	–	﹤0.01%	6311
2024 Q2	$52	Sell	2 -2	-50%	-$99	﹤0.01%	6317
2024 Q1	$160	Buy	4 +2	+100%	+$100	﹤0.01%	6549
2023 Q4	$78	Buy	+2	New	+$84	﹤0.01%	6831
2023 Q3	–	Hold	0	–	–	–	7129
2023 Q2	–	Hold	0	–	–	–	7224
2023 Q1	–	Sell	-2	Closed	-$88	–	7304
2022 Q4	$95	Hold	2	–	–	﹤0.01%	6808
2022 Q3	$0	Sell	2 -2	-50%	-$88	﹤0.01%	7253
2022 Q2	$0	Hold	4	–	–	﹤0.01%	7383
2022 Q1	$0	Buy	4 +2	+100%	+$96	﹤0.01%	7700
2021 Q4	$0	Hold	2	–	–	﹤0.01%	7714
2021 Q3	$0	Hold	2	–	–	﹤0.01%	7425
2021 Q2	$0	Hold	2	–	–	﹤0.01%	7351
2021 Q1	$0	Sell	2 -6	-75%	-$237	﹤0.01%	7300
2020 Q4	$0	Buy	8 +4	+100%	+$140	﹤0.01%	6934
2020 Q3	$0	Hold	4	–	–	﹤0.01%	6805
2020 Q2	$0	Hold	4	–	–	﹤0.01%	6734
2020 Q1	$0	Hold	4	–	–	﹤0.01%	6704
2019 Q4	$0	Buy	+4	New	+$112	﹤0.01%	6676
2019 Q2	–	Sell	-4	Closed	-$99	–	6579
2019 Q1	$0	Buy	+4	New	+$101	﹤0.01%	6388
2018 Q4	–	Sell	-4	Closed	-$103	–	6580
2018 Q3	$0	Hold	4	–	–	﹤0.01%	6540
2018 Q2	$0	Buy	+4	New	+$88	﹤0.01%	6528
2017 Q2	–	Sell	-4	Closed	-$74	–	6410
2017 Q1	$0	Buy	+4	New	+$67	﹤0.01%	6468
2016 Q4	–	Sell	-4	Closed	-$61	–	6420
2016 Q3	$0	Hold	4	–	–	﹤0.01%	6320
2016 Q2	$0	Hold	4	–	–	﹤0.01%	6287
2016 Q1	$0	Hold	4	–	–	﹤0.01%	6384
2015 Q4	$0	Buy	+4	New	+$64	﹤0.01%	6384
2015 Q3	–	Sell	-4	Closed	-$71	–	6405
2015 Q2	$0	Buy	+4	New	+$73	﹤0.01%	6481
2015 Q1	–	Sell	-1,616	Closed	-$27.2K	–	6324
2014 Q4	$25K	Buy	1,616 +16	+1%	+$236	﹤0.01%	5267
2014 Q3	$22K	Hold	1,600	–	–	﹤0.01%	5259
2014 Q2	$20K	Sell	1,600 -8	-0.5%	-$91	﹤0.01%	5375
2014 Q1	$18K	Hold	1,608	–	–	﹤0.01%	5251
2013 Q4	$16K	Hold	1,608	–	–	﹤0.01%	5074
2013 Q3	$14K	Hold	1,608	–	–	﹤0.01%	5052
2013 Q2	$12K	Buy	+1,608	New	+$12.2K	﹤0.01%	5014

Other funds holding RXL

CAS

Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

CIAS

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Wells Fargo's RXL Position: Q2 2026 in Review

Wells Fargo held its ProShares Ultra Health Care (RXL) position steady in Q2 2026 at 1 share worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #6676.

Wells Fargo first reported a position in RXL in Q2 2013 and has held it in 39 quarters since. The position peaked at $25K in Q4 2014. 16 funds tracked by Wall St. Rank hold RXL as of Q2 2026.

Wells Fargo held 1 share of ProShares Ultra Health Care worth $75 as of Q2 2026.
Wells Fargo left its ProShares Ultra Health Care share count unchanged in Q2 2026.
ProShares Ultra Health Care made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6676 holding.
Wells Fargo first reported a position in ProShares Ultra Health Care in Q2 2013 and has held it in 39 quarters since.
Wells Fargo's ProShares Ultra Health Care position peaked at $25K in Q4 2014.
16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.